HealthInvest Partners’s Disc Medicine IRON Stock Holding History

HealthInvest Partners’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.19M	Sell	43,682 -63,573	-59%	-$4.37M	0.86%	36
2026 Q1	$3.19M	Buy	107,255 +59,288	+124%	+$4.11M	1.03%	33
2025 Q4	$3.81M	Buy	47,967 +2,277	+5%	+$192K	1.22%	29
2025 Q3	$321K	Buy	45,690 +21,038	+85%	+$1.25M	1.19%	28
2025 Q2	$1.31M	Buy	+24,652	New	+$1.16M	0.56%	35

Other funds holding IRON

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Eleva Capital Paris, France $343M AUM

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

HealthInvest Partners's IRON Position: Q2 2026 in Review

HealthInvest Partners reduced its Disc Medicine (IRON) stake by 59% in Q2 2026, selling an estimated $4.37M and leaving 43,682 shares worth $3.19M. The position accounts for 0.86% of the portfolio, ranked #36.

HealthInvest Partners first reported a position in IRON in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.81M in Q4 2025. 23 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

HealthInvest Partners held 43,682 shares of Disc Medicine worth $3.19M as of Q2 2026.
HealthInvest Partners sold 63,573 Disc Medicine shares in Q2 2026, an estimated $4.37M.
Disc Medicine made up 0.86% of HealthInvest Partners's portfolio in Q2 2026, its #36 holding.
HealthInvest Partners first reported a position in Disc Medicine in Q2 2025 and has held it in 5 quarters since.
HealthInvest Partners's Disc Medicine position peaked at $3.81M in Q4 2025.
23 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.